Follow-The-Filings

Security · featured owners

ABEO Abeona Therapeutics Inc.

Health Care COM NEW Equity as of 2026 Q2 among managers we track

  • 1 Owner
  • Max 0.1%
  • $673K

ABEO (Abeona Therapeutics Inc.) is held in 1 featured 13F book as of 2026 Q2. Palo Alto Investors is the largest tracked holder by portfolio weight (0.09%). Figures are as-filed 13F, not free float.

Who owns this now

Largest portfolio weights among featured holders · max 0.1% (Palo Alto Investors) · not free-float ownership

  1. Palo Alto Investors 0.09%

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
Palo Alto Investors 2026 Q2 0.09% Hold 108,865 $673K history

1 current · options excluded

SEC filings

Recent issuer filings from EDGAR · 16 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 7.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
424B3 Filing Doc
8-K 5.02 Filing Doc
8-K 5.07 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 8.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
DEFA14A Filing Doc
8-K 5.02,7.01,9.01 Filing Doc
8-K 5.03,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-K Filing Doc
8-K 8.01,9.01 Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 16 rows shown

Filed Form Detail Links
4 Period Sep 1, 2026 Filing Doc
4 Period Jul 21, 2026 Filing Doc
4 Period Jul 9, 2026 · 4 forms Filing Doc
4 Period Jun 30, 2026 Filing Doc
4 Period Jun 16, 2026 Filing Doc
4 Period Jun 15, 2026 Filing Doc
4 Period Jun 8, 2026 · 4 forms Filing Doc
4 Period May 26, 2026 Filing Doc
4 Period May 22, 2026 Filing Doc
4 Period May 15, 2026 Filing Doc
4 Period May 11, 2026 Filing Doc
4 Period Apr 1, 2026 Filing Doc
4 Period Mar 31, 2026 Filing Doc
4 Period Mar 16, 2026 Filing Doc
4 Period Feb 2, 2026 Filing Doc
4 Period Feb 2, 2026 · 3 forms Filing Doc

Updated about 2 hours ago Source: SEC EDGAR submissions All on EDGAR

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $3.5M — $5.82M
Gross profit * — — $4.29M
Gross margin * — — 73.7%
Net income -$54.19M -$63.73M $71.18M
Net margin * -1548.2% — 1223.1%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $55.74M $100.85M $204.91M
Total non-current assets * $8.26M $8.08M $14.66M
Total assets $64M $108.93M $219.57M
Total current liabilities $13.42M $16.59M $29.57M
Total non-current liabilities * $35.75M $48.31M $30.78M
Total equity $14.83M $44.03M $159.22M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$37.01M -$56.02M -$76.33M
Cash from investing $0.208M -$39.24M $105.03M
Cash from financing $37.06M $104.14M $26.04M
Net change in cash $0.256M $8.88M $54.74M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders